PALISADE BIO, INC. (PALI) › Operating IncomePALISADE BIO, INC. (PALI) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: -$10.47M2010: -$15.18M2011: -$12.99M2012: -$10.16M2013: -$12.52M2014: -$17.44M2015: -$19.16M2016: -$20.64M2017: -$13.31M2018: -$8.26M2019: -$8.63M2020: -$9.30M2021: -$41.85M2022: -$15.72M2023: -$13.07M2024: -$14.86M2025: -$18.06M-$18.06M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$18.06M-21.5%2024-$14.86M-13.7%2023-$13.07M+16.9%2022-$15.72M+62.4%2021-$41.85M-350.2%2020-$9.30M-7.7%2019-$8.63M-4.5%2018-$8.26M+37.9%2017-$13.31M+35.5%2016-$20.64M-7.7%2015-$19.16M-9.9%2014-$17.44M-39.2%2013-$12.52M-23.3%2012-$10.16M+21.8%2011-$12.99M+14.5%2010-$15.18M-45.1%2009-$10.47M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share